Sirtratumab vedotin Antibody
Sirtratumab vedotin (ASG15-ME) is an antibody-drug conjugate (ADC) targeting SLITRK6, which delivers the cytotoxic agent MMAE via a cleavable linker. This ADC is utilized in cancer research, particularly for investigating targeted therapies in preclinical in vitro and in vivo models of SLITRK6-expressing tumors.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Conjugation
Unconjugated
Concentration
2.57 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6205606 1.0 µg DNA
Ap1ar sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details 
R1260-05-ML750 100 µL
RCC1-like G Exchanging Factor, NT (RCC1 And BTB Domain-containing Protein 2, Regulator Of Chromosome Condensation And BTB Domain-containing Protein 2, Chromosome Condensation 1-like, CHC1-L, CHC1L, RLG, RCBTB2) (MaxLight 750) discontinued
Sign In for Pricing
View Details Z0773-AP 100 µL
ZO-3, CT (Tight Junction-associated Polypeptide, Zonula Occludens 3) (AP) discontinued
Sign In for Pricing
View Details